Published in Hypertension on November 01, 1991
Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol (2009) 1.56
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation (2010) 1.08
Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol (2011) 1.08
Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem J (1992) 1.07
Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes. Microcirculation (2005) 0.96
Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. J Clin Invest (1994) 0.94
Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med (2013) 0.94
Feasibility of dynamic CT-based adenosine stress myocardial perfusion imaging to detect and differentiate ischemic and infarcted myocardium in an large experimental porcine animal model. Int J Cardiovasc Imaging (2014) 0.89
Comparative transcriptome analysis of Bacillus subtilis responding to dissolved oxygen in adenosine fermentation. PLoS One (2011) 0.88
Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest (1998) 0.86
Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses. Coron Artery Dis (2014) 0.83
Protective Effects of Quercetin on Rat Pial Microvascular Changes during Transient Bilateral Common Carotid Artery Occlusion and Reperfusion. Front Physiol (2012) 0.81
Activation of ecto-5'-nucleotidase and cardioprotection by ischemic preconditioning. Basic Res Cardiol (1996) 0.80
Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events. Coron Artery Dis (2016) 0.79
Stimulation of alpha 1-adrenoceptors and protein kinase C-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo. J Physiol (1997) 0.77
Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-α (TNFα) concentration in chronic heart failure. EXCLI J (2014) 0.76
It is time to ask what adenosine can do for cardioprotection. Heart Vessels (1998) 0.76
Features of adenosine metabolism of mouse heart. Purinergic Signal (2006) 0.75
Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes. J Clin Invest (1994) 0.75
The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in Chinese. Int J Mol Sci (2014) 0.75
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest (2001) 2.19
Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci U S A (1987) 1.80
Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth (2007) 1.70
Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation (1991) 1.60
Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning". J Am Coll Cardiol (1995) 1.54
Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. J Am Coll Cardiol (1997) 1.47
Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-dependent mechanisms in canine hearts. Cardiovasc Drugs Ther (2001) 1.39
Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res (1990) 1.27
Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol (1986) 1.26
Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation (1998) 1.25
Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am J Cardiol (1996) 1.25
Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation (1999) 1.16
Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation (1997) 1.12
Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol (2001) 1.08
The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells. Pflugers Arch (1998) 1.06
23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am J Physiol (1990) 1.05
Loading sequence is a major determinant of afterload-dependent relaxation in intact canine heart. Am J Physiol (1985) 1.03
Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol (1999) 1.03
NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na(+)-H+ exchange. Am J Physiol (1993) 1.03
Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics J (2006) 1.02
Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system? J Heart Lung Transplant (2008) 1.00
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol (1997) 0.98
Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol (2001) 0.98
Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol (1993) 0.98
Plasma adenosine levels increase in patients with chronic heart failure. Circulation (1997) 0.96
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation (2001) 0.95
Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension (1997) 0.95
Ca2+ transients in perfused hearts revealed by gated 19F NMR spectroscopy. Circ Res (1988) 0.95
Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res (2001) 0.93
Alpha 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ Res (1987) 0.91
Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity. Am J Physiol (1996) 0.91
Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis. J Am Coll Cardiol (1994) 0.90
Bradykinin mediation of Ca(2+)-activated K+ channels regulates coronary blood flow in ischemic myocardium. Circulation (1997) 0.90
Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation (1996) 0.89
Reperfusion after brief ischemia disrupts the microtubule network in canine hearts. Circ Res (1993) 0.88
Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol (1997) 0.88
Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg (2000) 0.87
Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J (1997) 0.87
Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy. Heart (2005) 0.86
Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest (1998) 0.86
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Hypertension (2001) 0.86
Roles of NO and Ca2+-activated K+ channels in coronary vasodilation induced by 17beta-estradiol in ischemic heart failure. FASEB J (1997) 0.86
Effect of acute dynamic exercise on circulating plasma nitric oxide level and correlation to norepinephrine release in normal subjects. Am J Cardiol (1997) 0.84
Implication of protein kinase C-alpha, delta, and epsilon isoforms in ischemic preconditioning in perfused rat hearts. J Biochem (1997) 0.83
Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol (1999) 0.83
Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation (1991) 0.83
Impact of coronary risk factors on contribution of nitric oxide and adenosine to metabolic coronary vasodilation in humans. J Am Coll Cardiol (1998) 0.82
Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation (1998) 0.81
Nitric oxide mediates protein kinase C isoform translocation in rat heart during postischemic reperfusion. Biochim Biophys Acta (1999) 0.81
Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning. Circulation (1997) 0.81
Genetic variations and haplotype structures of the ABCB1 gene in a Japanese population: an expanded haplotype block covering the distal promoter region, and associated ethnic differences. Ann Hum Genet (2006) 0.81
Intracoronary administration of adenosine triphosphate increases myocardial adenosine levels and coronary blood flow in man. Jpn Circ J (1997) 0.80
Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Br J Pharmacol (1997) 0.80
Bidirectional effects of aminophylline on myocardial ischemia. Circulation (1995) 0.79
Endogenous adenosine blunts beta-adrenoceptor-mediated inotropic response in hypoperfused canine myocardium. Circulation (1992) 0.79
Nifedipine limits infarct size via NO-dependent mechanisms in dogs. Basic Res Cardiol (2001) 0.79
Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun (1995) 0.78
Adenosine inhibits leukocyte-induced vasoconstriction. Am J Physiol (1996) 0.78
Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. Circulation (1997) 0.78
Genetic polymorphisms and haplotypes of the human cardiac sodium channel alpha subunit gene (SCN5A) in Japanese and their association with arrhythmia. Ann Hum Genet (2005) 0.78
Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics. Arzneimittelforschung (1984) 0.78
Impaired cardiac response to exercise in post-menopausal women: relationship with peripheral vascular function. Nucl Med Commun (2003) 0.78
Increased cardiac levels of nitric oxide in patients with chronic heart failure. Am J Cardiol (2000) 0.77
Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization. Circulation (1993) 0.77
Alpha 2-adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol (1988) 0.77
Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: implication for coronary arteriosclerosis. Cardiovasc Drugs Ther (2001) 0.77
Altered loading sequence as an underlying mechanism of afterload dependency of ventricular relaxation in hearts in situ. Jpn Circ J (1985) 0.77
Cardioprotective effect of diadenosine tetraphosphate (AP4A) preservation in hypothermic storage and its relation with mitochondrial ATP-sensitive potassium channels. Transplantation (2000) 0.77
Beta-adrenergic stimulation disassembles microtubules in neonatal rat cultured cardiomyocytes through intracellular Ca2+ overload. Circ Res (1994) 0.77
Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. Heart Vessels (1994) 0.77
Increased membrane and soluble P-selectin in atrial fibrillation. Circulation (1999) 0.77
Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina. J Am Coll Cardiol (1998) 0.77
Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris. Am J Cardiol (1997) 0.77
Alpha 2-adrenoceptor stimulation can augment coronary vasodilation maximally induced by adenosine in dogs. Am J Physiol (1989) 0.77
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning. Ann Thorac Surg (2000) 0.77
Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway. Arterioscler Thromb Vasc Biol (1995) 0.77
An increase in afterload augments ventricular relaxation rate in isolated perfused canine hearts. Cardiovasc Res (1985) 0.76
AICA riboside improves myocardial ischemia in coronary microembolization in dogs. Am J Physiol (1994) 0.76
Doxorubicin, to treat cancers or to cause cardiac injury, that is the question. Cardiovasc Drugs Ther (2001) 0.76
Delayed end ejection increases isovolumic ventricular relaxation rate in isolated perfused canine hearts. Circ Res (1991) 0.75
Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study. Heart Vessels (1992) 0.75
A possible model of the anginal syndrome with normal coronary arteriograms: microembolization of canine coronary arteries. Heart Vessels (1987) 0.75
It is the time to ask what adenosine can do for cardioprotection in ischemic heart disease. Intern Med (1999) 0.75
Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol (1989) 0.75
Ejection timing as a major determinant of left ventricular relaxation rate in isolated perfused canine heart. Circ Res (1984) 0.75
Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart. J Cardiovasc Pharmacol (1997) 0.75
Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury. Hypertension (1998) 0.75
Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart. Heart Vessels Suppl (1991) 0.75
Norepinephrine disrupts cytoskeletal framework of microtubules in rat hearts. Jpn Circ J (1992) 0.75
Disruption of microtubules in cultured neonatal rat cardiomyocytes during rapid contractions: protective effects of beta-adrenoceptor antagonist. Jpn Circ J (1992) 0.75
Roles of alpha 1-adrenoceptor activity in the release of nitric oxide during ischemia of the canine heart. Biochem Biophys Res Commun (1995) 0.75
Effects of ischemic preconditioning on contractile and metabolic function during hypoperfusion in dogs. Am J Physiol (1998) 0.75
Activated polymorphonuclear leukocytes induce constriction of canine coronary artery via Mac-1, but not LFA-1, and ICAM-1. J Mol Cell Cardiol (1996) 0.75
[alpha-adrenoceptor activity on regulation of cardiovascular system]. Tanpakushitsu Kakusan Koso (1990) 0.75
Downward shift of coronary pressure-flow relationship following a brief period of ischemia in dogs. Am J Physiol (1995) 0.75